by Kayt Sukel
Researchers investigate an FDA-approved diabetes drug that affects energy production in cells.by Jim Schnabel
Treating inherited retinal disease and deafness are likely near-term
applications.by Kayt Sukel
Synaptic-level changes encode memories in the short term. Could changes at the synapse-support structure, the perineuronal net, encode longer-lasting ones?by Guy McKhann, MD
by Carl Sherman
It's not easy for brain training companies to prove their products are truly helpful. That doesn't stop them from claiming they are. Our monthly column from Brain in the News.
DNA damage and repair
are widely studied by cancer biologists and immunologists; now neuroscientists
are taking a look.by Kayt Sukel
by David Hafler, MD, and Benjamin A. Lerner, AB
It’s difficult to know what motivates people, but R. Alison
Adcock’s lab is using imaging to study how states like desire and curiosity can
facilitate “motivated memory.” Her work could have implications in the
education field, but also in other learning contexts like psychotherapy and
behavior change. One of our series of Neuroscientist Q&As.
While our understanding of relapsing remitting disease and treatment options have expanded enormously in recent years, understanding the mechanism of secondary and primary progressive MS, including the neurodegenerative aspects of these diseases, remains a central question. One of our series of Reports on Progress.